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Abstract
Background: The Wnt/β-catenin signaling pathway plays crucial roles in embryonic development
and in maintenance of organs and tissues in adults. Chibby (Cby) is an evolutionarily conserved
molecule that physically interacts with the key downstream coactivator β-catenin and represses its
transcriptional activation potential. Although Cby harbors a predicted coiled-coil motif in the C-
terminal region, its molecular nature and functional importance remain largely unexplored.
Results: Here we report that Cby forms a stable complex with itself. Alanine substitutions of two
or more of four critical leucine residues within the C-terminal heptad repeats completely eliminate
the Cby-Cby interaction. The Cby oligomer predominantly exists as a homodimer. Furthermore,
we found that dimerization-deficient Cby mutants still retain the ability to bind to β-catenin and to
repress β-catenin-dependent gene activation. More importantly, Cby homodimerization is required
for its efficient interaction with the nuclear import receptor importin-α and subsequent nuclear
translocation.
Conclusion: Our comprehensive mutational analysis of the Cby coiled-coil domain reveals that
the four heptad leucine residues play an essential role in mediating Cby homodimerization.
Although monomeric Cby is sufficient to bind to β-catenin and block β-catenin-mediated
transcriptional activation, homodimer formation of Cby is indispensable for its efficient nuclear
import.
Background
Intracellular signaling activated by the Wnt family of
secreted cysteine-rich glycoproteins is crucial for embry-
onic development, stem cell self-renewal and adult home-
ostasis [1-3]. More recently, dysregulation of Wnt
signaling has been linked to a range of human diseases,
especially cancer [4-6]. For instance, canonical Wnt/β-cat-
enin signaling is aberrantly activated in greater than 70%
of colorectal cancers, promoting cancer cell proliferation,
survival and migration [7,8]. Accordingly, the Wnt/β-cat-
enin pathway has gained recognition as an enticing
molecular target for cancer therapeutics [9,10]. In this sig-
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naling cascade, β-catenin plays a pivotal role as a tran-
scriptional coactivator [11,12]. In the absence of a Wnt
ligand, cytoplasmic β-catenin becomes phosphorylated
by casein kinase 1 (CK1) and glycogen synthase kinase 3
(GSK3) in a complex containing the tumor suppressors
Axin and Adenomatous polyposis coli (APC), and is tar-
geted for ubiquitin-mediated proteasomal degradation
[13,14]. Wnt binding to the seven transmembrane Friz-
zled (Fz) receptors and the low-density lipoprotein recep-
tor-related protein (LRP) co-receptors, LRP5 and LRP6,
triggers recruitment of Axin to the plasma membrane,
resulting in inhibition of β-catenin phosphorylation and
degradation [15,16]. As a consequence, β-catenin accu-
mulates in the cytoplasm and then translocates into the
nucleus where it forms a complex with the T-cell factor/
lymphoid enhancer factor (Tcf/Lef) family of transcrip-
tion factors, leading to activation of target genes [17,18].
We previously reported a β-catenin antagonist Chibby
(Cby) [19]. The human Cby protein is composed of 126
amino acids, and is highly conserved throughout evolu-
tion. Cby physically interacts with the C-terminal activa-
tion domain of β-catenin. Our recent crystal structural
studies for a full-length β-catenin suggest that Cby binds
to the Helix C located at the C-terminal end of the central
Armadillo repeat region of β-catenin [20]. Cby functions
as a repressor of β-catenin by competing with Tcf/Lef fac-
tors for β-catenin binding. Reduction of Cby protein levels
in Drosophila melanogaster embryos by RNA interference
(RNAi) results in hyperactivation of this pathway
[19,21,22], underscoring the biological importance of
Cby's function. Using in vitro cell culture models, we dem-
onstrated that Cby facilitates adipocyte and cardiomyo-
cyte differentiation of pluripotent stem cells through
inhibition of β-catenin signaling [23,24]. More recently,
we isolated 14-3-3 adaptor proteins as novel Cby-binding
partners [25,26]. Upon phosphorylation of Cby serine 20
by Akt kinase, Cby and 14-3-3 form a stable trimolecular
complex with β-catenin, and cooperate to promote cyto-
plasmic localization of β-catenin, leading to down-regula-
tion of β-catenin-mediated transcriptional activation.
Therefore, we proposed a new model in which inhibition
of β-catenin signaling by Cby involves at least two distinct
molecular mechanisms, i.e. competing with Tcf/Lef tran-
scription factors for binding to β-catenin in the nucleus
[19], and facilitating nuclear export of β-catenin via inter-
action with 14-3-3, following phosphorylation of Cby ser-
ine 20 by Akt [25].
Through comparison of Cby protein sequences across spe-
cies, we noted that Cby contains a conserved putative
coiled-coil motif in its C-terminal region [19]. In a later
study, Hidaka et al. performed a yeast two-hybrid screen
using full-length human Cby as bait, and pulled out Cby
itself [27]. Their subsequent deletion analysis indicated
that the C-terminal region of human Cby protein encom-
passing the coiled-coil domain (amino acids 60–112) is
prerequisite for its self-association. However, the nature of
Cby homooligomers and specific amino acid residues
responsible for Cby self-assembly has remained to be elu-
cidated.
In the present study, we report that Cby forms a stable
homodimer via its C-terminal leucine zipper coiled-coil
domain. Using a variety of Cby point mutants generated
by site-directed mutagenesis, we found that four leucine
residues in the C-terminal heptad-repeat region are
responsible for Cby homodimerization. We also show
that Cby mutants defective in homodimer formation are
capable of both binding to β-catenin and antagonizing its
signaling activity. More importantly, we provide evidence
that Cby homodimerization is necessary for its efficient
binding to the nuclear import receptor importin-α and
subsequent nuclear import.
Results
Cby forms a stable oligomer
Cby has been shown to interact with itself using the con-
ventional yeast two-hybrid system [27]. In order to con-
firm and further extend this observation, we examined
whether Cby forms a complex with itself in mammalian
cultured cells by coimmunoprecipitation experiments
(Figure 1A). Cell lysates from human embryonic kidney
(HEK) 293T cells co-transfected with Myc- and Flag-
tagged Cby expression constructs were immunoprecipi-
tated with anti-Myc antibody and analyzed by Western
blotting using anti-Flag antibody. A specific interaction
was reproducibly observed between the Cby proteins
(lane 3).
Next, split synthetic Renilla luciferase (hRluc) assays [28]
were employed as an independent means to verify the
Cby-Cby interaction. To this end, Cby or negative control
GFP was fused in-frame to the N-terminal portion of
hRluc (Cby-RN or GFP-RN) or to the C-terminal portion
of hRluc (Cby-RC or GFP-RC). Physical interactions
between fusion proteins would bring the N-terminal and
C-terminal portions of hRluc together and restore its activ-
ity. The constructs were transfected into HEK293T cells in
various combinations and hRluc activities were measured.
As shown in Figure 1B, co-transfection of empty vectors
(RN and RC) or Cby- and GFP-hRluc fusion plasmids
(Cby-RN and GFP-RC or GFP-RN and Cby-RC) produced
only a basal level of hRluc activity. In contrast, robust
hRluc activity was observed when Cby-RN and Cby-RC
were coexpressed. We also utilized a cell-permeable sub-
strate for Renilla luciferase (ViviRen) to detect protein-
protein interactions in live cells in real time. Figure 1C
demonstrates that transient co-transfection of Cby-RN
and Cby-RC expression vectors into HEK293T cellsBMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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resulted in a high luminescence value, whereas either vec-
tor in combination with an empty plasmid (RC or RN)
generated only low background luminescence. Interac-
tions between Cby and the well-established basic leucine
zipper (bZIP) coiled-coil transcription factors, Jun and
Fos, were also tested using the ViviRen live cell substrate.
No marked luminescence was detected when Cby-RN and
Fos-RC or Jun-RN and Cby-RC were coexpressed in
HEK293T cells, compared to that of Jun-Fos and Cby-Cby
interactions, suggesting that the Cby-Cby interaction is
specific.
Furthermore, we examined the stability of the Cby oli-
gomer (Figure 1D). Flag-Cby and HA-Cby expression plas-
mids were co-transfected into HEK293T cells, and cell
lysates were immunoprecipitated with anti-HA antibody.
The immunoprecipitates were then exposed to increasing
concentrations of NaCl or urea as indicated, resolved by
Cby forms a stable complex with itself Figure 1
Cby forms a stable complex with itself. (A) Coimmunoprecipitation of Myc-Cby and Flag-Cby. (B) Cby self-interaction 
was detected by split synthetic Renilla luciferase (hRluc) protein-fragment-assisted complementation. Cby or negative control 
GFP was fused in-frame to the N-terminal portion (RN) and C-terminal portion (RC) of hRluc. These expression plasmids (400 
ng each) were transfected into HEK293T cells as indicated, and Renilla luciferase (Rluc) activities were measured 24 hr post-
transfection. A firefly luciferase plasmid (5 ng) was co-transfected to normalize transfection efficiency. Transfections were car-
ried out in triplicate and the means ± SD are shown.(C) Cby-Cby interactions were detectable in vivo in real time using cell-
permeable ViviRen live cell substrate. Cby-RN, Cby-RC, Fos-RC and Jun-RN were transiently expressed in HEK293T cells as 
shown, and ViviRen was added to the tissue culture media 24 hr post-transfection for luminescence measurements. Transfec-
tions were carried out in triplicate and the means ± SD are shown.(D) Cby complex is highly stable. The immunoprecipitates 
were washed three times with wash buffer containing 0.135, 0.5, 1.0, 1.5 or 2.0 M NaCl, or 0.5, 1.0, 1.5 or 2.0 M urea as 
shown. The experiments with urea were performed in the presence of 0.135 M NaCl.BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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SDS-PAGE, and analyzed by immunoblotting using anti-
Flag antibody. Essentially, a similar amount of Flag-Cby
was detected in the presence of up to 2 M NaCl or 2 M
urea. These results indicate that the Cby oligomer is highly
stable and that both electrostatic and hydrophobic inter-
actions may contribute to the stability of the Cby com-
plex.
Cby is present as a homodimer
To gain insights into the oligomeric nature of Cby, we per-
formed gel filtration chromatography. His-tagged Cby
was purified from stable HEK293T cells using nickel beads
and applied to a Superdex 75 column. Following fraction-
ation, each fraction was examined by immunoblotting
using anti-Cby antibody. As shown in Figure 2A, Cby
eluted as a broad single peak centered at fraction 34, cor-
responding to a molecular weight of about 45 kDa. Since
the molecular weight of a His-Cby monomer is 22 kDa,
we estimated that Cby is most likely to be present as a
homodimer.
As an independent means, we conducted glutaraldehyde
cross-linking analysis. For this purpose, His-tagged Cby
was transiently expressed in HEK293T cells, and purified
using nickel beads. The purified Cby protein was then
incubated in the presence or absence of glutaraldehyde for
5 or 20 min, and the cross-linked proteins were resolved
by SDS-PAGE, followed by Western blot analysis with
anti-Cby antibody (Figure 2B). As expected, in the absence
of glutaraldehyde, His-Cby had an apparent monomer
Cby exists as a homodimer Figure 2
Cby exists as a homodimer. (A) Gel filtration analysis of Cby. His-Cby purified from stable HEK293T cells was run on a 
pre-calibrated Superdex 75 FPLC column in buffer containing 1 M NaCl. An aliquot of each fraction was resolved by SDS-PAGE 
and analyzed by Western blotting using anti-Cby antibody. The arrows indicate the elution positions of protein standards: aldo-
lase, 158 kDa; bovine serum albumin, 67 kDa; ovalbumin, 45 kDa and cytochrome C, 12 kDa. Similar results were obtained 
using buffer containing 0.5 M NaCl (data not shown). (B, C) Cross-linking experiments. His-tagged Cby was purified from 
transiently transfected HEK293T cells using Ni-NTA beads, and subjected to cross-linking with glutaraldehyde for 5 or 20 min 
(B), or dimethyl suberimidate (DMS) for 30 min (C). The samples were then resolved by SDS-PAGE, followed by immunoblot-
ting with anti-Cby antibody.BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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molecular weight of 22 kDa. On the other hand, after
incubating with glutaraldehyde, His-Cby migrated slower
at a higher molecular weight of approximately 44 kDa.
Similar results were also observed using dimethyl suber-
imidate (DMS), another cross-linking reagent that con-
tains a longer spacer arm (Figure 2C). All together, these
results suggest that Cby predominantly exists as a
homodimer.
Cby harbors a putative leucine zipper coiled-coil motif in 
its C-terminal region
In our previous study [19], through inspection of the Cby
protein sequence, we noted the presence of a putative
coiled-coil motif in its C-terminal region. Coiled coils are
a supercoiled bundle of α-helices known to mediate pro-
tein oligomerization [29,30]. Further analysis of the
human Cby amino acid sequence using the COILS pro-
gram [31,32] predicted a high probability of an α-helical
coiled-coil structure extending from amino acids 68 to
102 (Figure 3A). Visual examination of this segment
revealed four leucine residues that appear at every seventh
position (Figure 3B), characteristic of a leucine zipper
coiled-coil motif [33,34]. The sequence alignment of the
Cby coiled-coil domain across species shows that these
four leucines are perfectly conserved in vertebrate Cby
homologues. On the contrary, only the first two leucine
residues (L77 and L84) are conserved in fruit fly D. mela-
nogaster Cby. Nonetheless, the corresponding region of D.
melanogaster Cby was also predicted to form a coiled-coil
structure by the COILS program (data not shown), signi-
fying the functional importance of this domain. As
depicted in Figure 3C, the coiled-coil domain of human
Cby comprises four consecutive heptad repeats with
amino acid positions labeled as a-g. Helical wheel projec-
tion of this region illustrates that the d positions are lined
with leucine residues (Figure 3D), as typically observed in
bZIP transcription factors [33,34]. The a and d positions
are occupied generally by hydrophobic residues that inter-
act with each other to form a hydrophobic core, while res-
idues in the other positions are often surface-exposed
[29,33,34]. Some of these exposed amino acid residues in
the heptad repeats of Cby might directly contact β-catenin
as the β-catenin-binding domain of Cby resides in its C-
terminal half [19]. Collectively, these observations raise
the possibility that the four heptad leucines may play an
essential role in mediating Cby homodimerization.
Cby self-interaction is mediated by the conserved leucine 
residues within the C-terminal heptad-repeat motif
To test the hypothesis that the four leucine residues in the
C-terminal coiled-coil motif (L77, L84, L91 and L98) are
critical for Cby self-assembly, we performed site-directed
mutagenesis to substitute each leucine for an alanine in all
possible combinations. These mutations would not be
expected to disrupt the α-helical structure of Cby, but the
shorter alanine side chain would not be able to mediate a
leucine zipper-mediated stable coiled-coil configuration.
Upon overexpression of N-terminally Flag-tagged pro-
teins in HEK293T cells, all Cby mutants were detected at
appreciable levels by Western blotting using anti-Flag
antibody (Figure 4A). Next, the Cby mutants were evalu-
ated for their ability to form a complex with wild-type Cby
(CbyWT) by coimmunoprecipitation assays (Figure 4B).
Individual Flag-tagged Cby mutant was coexpressed with
HA-tagged CbyWT in HEK293T cells, and cell lysates were
immunoprecipitated with anti-HA antibody and sub-
jected to Western blot analysis with anti-Flag antibody.
Cby single-point mutants were all able to interact with
CbyWT although reduced interactions were noted for
CbyL84A. Remarkably, Cby mutants carrying alanine sub-
stitutions for two or more out of the four leucine residues
completely abolished their interaction with CbyWT. To
validate these data, we carried out split hRluc assays for
self-associations between Cby point mutants (Figure 4C).
Coexpression of CbyWT-hRluc fusion proteins in
HEK293T cells yielded high Rluc activity. Consistent with
the coimmunoprecipitation experiments, reduced, yet sig-
nificant Rluc activities were observed for Cby single-point
mutants, whereas all Cby double mutants or the quadru-
ple mutant (Cby4A) displayed only marginal Rluc activi-
ties.
To investigate if Cby mutants incapable of self-interaction
are compromised in homodimer formation, we per-
formed glutaraldehyde cross-linking experiments. As
shown in Figure 5, CbyWT migrated as a dimer (lane 2)
but CbyL77A/L91A and Cby4A migrated as a monomer
(lanes 4 and 6, respectively) in SDS-PAGE. These data
clearly highlight the functional importance of the heptad
leucine residues in mediating Cby homodimerization.
Cby self-association is not required for its interaction with 
β-catenin and inhibition of β-catenin-dependent 
transcriptional activation
Cby physically interacts with the C-terminal activation
domain of β-catenin, and inhibits β-catenin-dependent
gene activation [19]. We took advantage of Cby dimeriza-
tion-deficient mutants to examine whether the
homodimer formation of Cby is a prerequisite for control-
ling β-catenin signaling. First, we assessed binding of Cby
mutants to β-catenin using in vitro pull-down assays (Fig-
ure 6A). Bacterially expressed and purified maltose-bind-
ing protein (MBP) or MBP-CbyWT, L77A, L91A, L77A/
L91A or 4A was incubated with His-tagged β-catenin C-
terminal region (Armadillo repeat 10 to the C-terminus; β
catR10-C) and pulled down with amylose beads. The
bound proteins were then resolved by SDS-PAGE and ana-
lyzed by immunoblotting using anti-β-catenin antibody.
Intriguingly, all the Cby point mutants tested, including
the ones defective in homodimerization (CbyL77A/L91ABMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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The C-terminal region of Cby harbors a putative coiled-coil motif Figure 3
The C-terminal region of Cby harbors a putative coiled-coil motif. (A) The human Cby protein sequence (126 amino 
acid residues) was analyzed by the COILS program at a window size of 21 residues. Note that high coiled-coil probabilities 
exceeding 0.9 were evident from amino acid 68 to 102. (B) Sequence alignment of the Cby coiled-coil domain across species. 
Identical and similar residues are highlighted in black and gray, respectively. Four leucines, indicated by asterisks, appear at 
every seventh position, indicative of a leucine-zipper motif. (C) The putative coiled-coil motif of human Cby is depicted as hep-
tad repeats of seven amino acids. The letters a through g designate the positions of residues within the heptad with hydropho-
bic residues generally found at the a and d positions. The four consecutive heptads are numbered 1 through 4. Note that the d 
positions are occupied by leucine residues.(D) Helical wheel diagram of the coiled-coil domain of human Cby (amino acids 77–
98).BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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Figure 4 (see legend on next page)BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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and Cby4A), efficiently bound to β-catenin. Next, we per-
formed Tcf/Lef luciferase reporter (TOPFLASH) assays
[35] in HEK293T cells using the Cby mutants. Transfec-
tion of stabilized β-catenin activated TOPFLASH activity
near 25-fold (Figure 6B). Co-transfection of CbyWT
potently repressed β-catenin-mediated transcriptional
activation in a dose-dependent manner. In agreement
with the coimmunoprecipitation data, all the Cby point
mutants inhibited TOPFLASH activation by β-catenin to
an extent similar to that of CbyWT. In all cases, no or little
changes were observed with the control reporter FOP-
FLASH carrying mutated Tcf/Lef-binding sites. Taken
together, these results suggest that the monomeric form of
Cby is sufficient for binding to β-catenin and for inhibit-
ing β-catenin signaling activity.
Cby homodimerization ensures its efficient nuclear entry
Our recent studies indicate that Cby harbors a functional
nuclear localization signal (NLS) at the C-terminal end
and a nuclear export signal (NES) in the N-terminal
region, and constitutively shuttles between the nucleus
and cytoplasm [25] (F.-Q. Li et al., manuscript submitted).
Worthy of note, it has been reported that dimerization is
a prerequisite process for the nuclear import of STAT,
SREBP2 and viral IE1 transcription factors [36-38].
The heptad leucine residues within the coiled-coil domain are crucial for Cby homodimerization Figure 4 (see previous page)
The heptad leucine residues within the coiled-coil domain are crucial for Cby homodimerization. (A) Expression 
levels of Cby point mutants. Lysates from HEK293T cells transfected with an equal amount (600 ng) of an expression plasmid 
for Flag-tagged wild-type (WT) or mutant Cby were subjected to Western blotting with an anti-Flag antibody. (B) Cell lysates 
were prepared from HEK293T cells transiently co-transfected with HA-CbyWT and Flag-CbyWT or individual Cby variants 
with all possible combinations of leucine-to-alanine mutations [single, double, triple and quadruple (4A)], and subjected to 
immunoprecipitation with anti-HA antibody. The immunoprecipitates were separated by SDS-PAGE and immunoblotted with 
anti-Flag antibody. To ensure sufficient protein expression levels, the amounts of plasmid DNA expressing Flag-tagged Cby 
mutants were increased by 2-fold for transfection, compared to those of Flag-CbyWT plasmid. (C) Split hRluc protein-frag-
ment-assisted complementation assays using Cby point mutants. CbyWT or each of the indicated Cby mutants was fused in-
frame to RN and RC. These expression plasmids (400 ng each) were transfected into HEK293T cells, and Rluc activities were 
measured as described in the legend to Figure 1B. Transfections were carried out in triplicate and the means ± SD are shown. 
Immunoblotting with anti-Cby antibody showed that the fusion proteins were stably expressed. Cby-RN fusion proteins 
appear as a doublet probably due to degradation.
Glutaraldehyde cross-linking of dimerization-deficient Cby mutants Figure 5
Glutaraldehyde cross-linking of dimerization-deficient Cby mutants. His-tagged CbyWT, L77A/L91A or 4A was tran-
siently expressed in HEK293T cells, and purified using Ni-NTA beads. The purified Cby protein was incubated in the absence 
or presence of glutaraldehyde for 5 min, and resolved on SDS-PAGE, followed by immunoblotting with anti-Cby antibody.BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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To begin to understand the biological significance of Cby
homooligomerization, we assessed the subcellular locali-
zation of Cby mutants. In contrast to the diffuse cytoplas-
mic and nuclear distribution of N-terminally tagged
CbyWT (Figure 7B) [25] and untagged CbyWT (data not
shown), we noted that C-terminally tagged CbyWT
(CbyWT-Flag) shows almost complete nuclear localiza-
tion (Figure 7A), most likely due to a conformational
change that exposes the normally buried C-terminal NLS.
Notably, the dimerization-deficient mutant CbyL77A/
L91A-Flag exhibited increased cytoplasmic staining, while
both CbyL77A-Flag and CbyL91A-Flag mutants capable
of self-interaction displayed predominant nuclear locali-
zation (Figure 7A). To confirm these results, we next eval-
uated the intracellular localization of N-terminally Flag-
tagged Cby protein (Flag-Cby). Consistent with our previ-
ous observation [25], when expressed in COS7 cells, Flag-
CbyWT primarily localized to the cytoplasm or both the
nucleus and cytoplasm, especially in cells with high levels
of Cby expression (Figure 7B and 7C). This cellular local-
ization pattern of Flag-CbyWT is essentially the same as
that of untagged protein (data not shown). In contrast,
Flag-CbyL77A/L91A defective in dimer formation showed
a subtle yet significant shift towards cytoplasmic localiza-
tion. This trend became more apparent when cells were
treated with leptomycin B (LMB), a potent inhibitor of the
nuclear export receptor CRM1 [39,40]. Following LMB
treatment, Flag-CbyWT was mostly nuclear but a signifi-
cant fraction of Flag-CbyL77A/L91A was found in the
cytoplasmic compartment (Figure 7B and 7C). A similar
trend was observed with C-terminally Flag-tagged Cby
proteins (Additional file 1). These findings suggest that
homodimer formation of Cby is required for its efficient
nuclear import.
Our recent data indicate that the C-terminal classical NLS
of Cby physically interacts with the nuclear import recep-
tor importin-α (F.-Q. Li et al., manuscript submitted). In
the classical nuclear import pathway, importin-α plays a
pivotal role by directly binding to NLS-containing pro-
teins, linking them to importin-β [41-43]. Importin-β in
turn docks the ternary import complex at the nuclear pore
complex (NPC) and facilitates its translocation into the
nucleus. In order to explore the molecular basis underly-
ing the nuclear import defect of Cby homodimer mutants,
we investigated interactions between Cby mutants and
importin-α3 using in vitro binding assays. Bacterially pro-
duced MBP or MBP-Cby was incubated with GST-impor-
tin-α3 and pulled down using amylose resin. After
extensive washing, the bound proteins were separated on
SDS-PAGE and immunoblotted with anti-GST antibody.
As shown in Figure 7D, the Cby single point mutants
L77A and L91A bound to importin-α3 albeit with a
slightly reduced affinity in comparison with CbyWT. On
the other hand, the dimerization-defective CbyL77A/
L91A exhibited a marked reduction in its ability to interact
with importin-α3. Collectively, our results suggest that
Cby homodimerization is a prerequisite for its efficient
interaction with importin-α and subsequent nuclear
translocation.
Discussion
The canonical Wnt/β-catenin signaling pathway is essen-
tial for numerous cellular processes during embryonic
development, tissue homeostasis and tumorigenesis.
Upon Wnt stimulation, β-catenin, the key downstream
component of this pathway, enters the nucleus and acts as
a transcriptional coactivator to up-regulate target gene
expression. Cby is an evolutionarily conserved protein
that directly binds to the C-terminal activation domain of
β-catenin and antagonizes its signaling activity [19]. Cby
has been shown to interact with itself through its C-termi-
nal region using yeast two-hybrid assays [27]. However,
the molecular basis for the Cby-Cby interaction has
remained largely uncharacterized to date.
Here we provide evidence that Cby forms a homodimer
via the leucine zipper coiled-coil motif in its C-terminal
Cby homodimerization is dispensable for its interaction with β-catenin and for repression of β-catenin signaling activity Figure 6 (see previous page)
Cby homodimerization is dispensable for its interaction with β-catenin and for repression of β-catenin signaling 
activity. (A) Binding of Cby point mutants to β-catenin was evaluated by in vitro pull-down assays. Bacterially produced MBP 
or individual MBP-Cby protein was incubated with His-tagged β-catenin C-terminal domain (His-βcatR10-C). The protein com-
plexes were then pulled down with amylose resin and subjected to Western blotting using anti-β-catenin antibody (top panel). 
The input lane was loaded with one-fiftieth of the amount of His-βcatR10-C used in the binding reactions (lane 1). One-thirti-
eth of each pull-down sample was run on a separate SDS-PAGE and immunoblotted with anti-MBP antibody, showing that sim-
ilar amounts of MBP-Cby protein were pulled down (bottom panel). (B) The ability of Cby mutants to repress β-catenin 
signaling was tested by TOPFLASH assays. HEK293T cells were transfected with 60 ng of TOPFLASH or mutant FOPFLASH 
luciferase reporter, with or without 40 ng of an expression vector for stabilized β-catenin (β-catenin-Myc), and the indicated 
amounts of a Flag-tagged Cby expression vector. Luciferase activity was measured 24 hr post-transfection, and normalized to 
Renila luciferase activity used as an internal control. Transfections were carried out in triplicate and the means ± SD are 
shown. Note that, to compensate protein levels, higher amounts of plasmid DNA for the Cby mutants were used for transfec-
tion.BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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region. The Cby complex is highly stable even in the pres-
ence of 2 M NaCl or 2 M urea (Figure 1D). We found that
the four leucine residues in the d position of the helical
wheel diagram (amino acids 77, 84, 91 and 98 in Figure
3D) are crucial for mediating Cby self-association.
Alanine mutagenesis of two or more leucines completely
abolishes the Cby-Cby interaction (Figures 4 and 5). Fur-
thermore, our data indicate that the Cby-Cby interaction
is not obligatory both for binding to β-catenin and for
suppressing its signaling activity (Figure 6). Instead,
homodimerization of Cby is a prerequisite process for its
efficient binding to importin-α and nuclear import (Fig-
ure 7).
α-Helical coiled-coil motifs are versatile domains that
mediate numerous protein-protein interactions [29,30].
The C-terminal coiled-coil motif of Cby is evolutionarily
conserved from fly to human, implying the biological
importance of this domain. Consistent with the presence
of the α-helical coiled-coil structure, circular dichroism
(CD) studies showed that Cby protein has a high α-helical
content [44]. Our cross-linking and gel filtration experi-
ments suggest that Cby predominantly forms a dimer
(Figure 2). However, it is also possible that Cby exists in a
larger oligomeric state under certain conditions as shown
for other coiled-coil proteins [29,30]. In order to gain fur-
ther insights into the molecular basis and functional sig-
nificance of the Cby-Cby interaction, it would be of great
interest to determine the three-dimensional structure of
the Cby complex. However, so far, Cby protein is insolu-
ble and forms inclusion bodies when expressed using bac-
terial as well as baculoviral expression systems (data not
shown), thereby impeding further structural and bio-
chemical analyses. We found that the aggregation of Cby
protein is mainly caused by the C-terminal coiled-coil
domain since the N-terminal half of the protein is highly
soluble in E. coli (data not shown).
Our recent data suggest that Cby harbors functional NLS
and NES motifs, and constantly cycles between the
nucleus and cytoplasm. Thus, it appears that Cby intracel-
lular localization at steady state is determined by a
dynamic balance between its nuclear import and export.
In this respect, Cby homodimerization represents a cru-
cial step for its efficient binding to importin-α and subse-
quent nuclear import. It is noteworthy that dimer
formation has been shown to be the key regulatory event
controlling the nuclear entry of STAT, SREBP2 and viral
IE1 transcription factors [36-38]. Nuclear import of STATs
is mediated by importin-α family members [37,45], but
that of SREBP2 depends on importin-β [38]. Interestingly,
binding of importin-α5 to STAT dimers strictly requires
two intact NLS elements, one in each STAT monomer
[37]. We therefore envision that the assembly of Cby into
dimers creates a fully functional NLS perhaps by juxtapos-
ing the NLS of each monomer, allowing its efficient bind-
ing to importin-α and subsequent nuclear import.
Alternatively, Cby oligomerization may induce a confor-
mational change that unmasks the NLS.
Our results clearly show that Cby mutants deficient in
self-interaction are capable of efficiently binding to β-cat-
enin, leading to repression of its signaling activity to a
similar extent as wild-type Cby (Figure 6), despite the fact
that these Cby mutants are predominantly cytoplasmic
(Figure 7). However, this is in agreement with our model
in which Cby inhibits β-catenin signaling through two
distinct molecular mechanisms [25,26]: 1) in the nucleus,
Cby competes with Tcf/Lef transcription factors for bind-
ing to β-catenin; 2) Cby sequesters β-catenin in the cyto-
plasm in collaboration with 14-3-3 proteins. Thus, we
speculate that monomeric Cby suppresses β-catenin sign-
aling by trapping β-catenin within the cytoplasmic com-
partment. Alternatively, a small portion of nuclear Cby
might be sufficient to repress β-catenin-mediated tran-
Homodimer formation of Cby is a prerequisite for its efficient nuclear import Figure 7 (see previous page)
Homodimer formation of Cby is a prerequisite for its efficient nuclear import. (A) C-terminally Flag-tagged 
CbyL77A/L91A accumulates in the cytoplasm. COS7 cells were transiently transfected with an expression vector encoding C-
terminally Flag-tagged WT or mutant Cby as indicated. Cells were fixed 24 hr post-transfection, followed by immunostaining 
with anti-Flag antibody. Nuclei were stained with DAPI. (B) A fraction of N-terminally Flag-tagged CbyL77A/L91A is found in 
the cytoplasm after LMB treatment. COS7 cells were transfected with an expression vector for N-terminally Flag-tagged 
CbyWT or CbyL77A/L91A, treated with methanol (- LMB) or 40 nM LMB (+ LMB) for 5 hr, and immunostained with anti-Flag 
antibody for Cby. Nuclei were counterstained with DAPI. (C) Quantitative analysis of the results in (B). The subcellular local-
ization of Flag-CbyWT and Flag-CbyL77A/L91A was scored as follows: N>C, predominantly nuclear; N = C, evenly distributed 
between the nucleus and cytoplasm; N<C, predominantly cytoplasmic. Error bars represent the means ± SD of three inde-
pendent experiments. (D) Reduced binding of CbyL77A/L91A to importin-α. Bacterially produced MBP or the indicated MBP-
Cby protein was incubated with GST-importin-α3. The complexes were then pulled down with amylose resin and subjected to 
Western blotting using anti-GST antibody (top panel). The input lane was loaded with one-fiftieth of the amount of GST-
importin-α3 used in the binding reactions (lane 1). One-thirtieth of each pull-down sample was run on a separate SDS-PAGE 
and immunoblotted with anti-MBP antibody, showing that similar amounts of MBP-Cby protein were pulled down (bottom 
panel).BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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scriptional activation since dimerization-deficient Cby
mutants are able to enter the nucleus, albeit at a reduced
rate (Figure 7B).
It is possible that the Cby-Cby interaction is of importance
in certain biological contexts other than β-catenin signal-
ing. For example, Cby has been shown to interact with
thyroid cancer-1 (TC-1) [46] and polycystin-2 (PC-2)
[27]. TC-1 was initially identified as a gene whose expres-
sion was elevated in thyroid cancers [47]. More recently,
TC-1 was shown to interact with Cby and stimulate β-cat-
enin signaling presumably by displacing Cby from β-cat-
enin [46]. However, its precise functions are not yet
completely understood. PC-2 is another known binding
partner of Cby [27]. The PDK-2 gene, encoding PC-2, is
mutated in patients with autosomal dominant polycystic
kidney disease [48,49]. A previous report showed that Cby
associates with PC-2 and regulates its subcellular distribu-
tion [27]. Hence, Cby appears to exert multiple biological
functions. Whether Cby self-association is involved in
controlling the activity of TC-1 and PC-2 awaits further
investigation.
Conclusion
In the present study, we demonstrated that Cby forms a
stable dimer through its C-terminal coiled-coil motif,
which consists of a heptad repeat of four conserved leu-
cine residues. Our extensive mutational analysis clearly
shows that these leucines are critical for Cby dimerization.
In addition, our results indicate that the Cby self-interac-
tion is dispensable for inhibition of β-catenin signaling
but is required for Cby nuclear import.
Methods
Plasmids
Expression vectors for Flag-CbyWT, MBP-CbyWT, β-cat-
enin-Myc and His-β catR10-C have been previously
described [19,50]. The GST-importin-α3 construct was a
kind gift from Dr. Nancy Reich at SUNY at Stony Brook
[45]. To generate Myc- and HA-tagged CbyWT expression
constructs, human Cby cDNA was excised from the Flag-
CbyWT vector with Eco RI and Xho I, and subcloned into
pCS2+Myc and pCS2+HA, respectively. A C-terminally
Flag-tagged CbyWT (CbyWT-Flag) plasmid was generated
by PCR amplification of human Cby cDNA using a 3'
primer containing a Flag sequence, digested with Eco RI
and Xho I and subcloned into pCS2+. Both N- and C-ter-
minally Flag-tagged Cby point mutants were created with
the QuickChange site-directed mutagenesis kit (Strata-
gene) using the Flag-tagged CbyWT vectors as templates.
To obtain His-CbyWT mammalian expression plasmid,
Cby cDNA was PCR-amplified, digested with Eco RI and
Xho I, and subcloned into pcDNA4/HisMax A (Invitro-
gen). His-CbyL77A/L91A and His-Cby4A expression vec-
tors were constructed by digesting the His-CbyWT
construct with Bam HI and Xho I, and replacing its insert
with the corresponding Cby mutant fragment from Flag-
CbyL77A/L91A and Flag-Cby4A plasmids, respectively.
To construct MBP-Cby mutants, the cDNA inserts were
PCR-amplified, digested with Bgl II and Xho I, and ligated
into pMAL-c2 (New England Biolabs). For synthetic
Renilla luciferase (hRluc) protein-fragment-assisted com-
plementation assays [28], cDNAs encoding Cby, GFP, Jun
or Fos were amplified by PCR using plasmid templates,
and ligated in-frame with the N-terminal portion (amino
acids 1–239) or the C-terminal portion (amino acids
240–321) of hRluc into the pJCH510 or pJCH511 vector
[25]. All constructs were verified by DNA sequencing.
Cell culture and transfection
HEK293T cells were purchased from ATCC, and main-
tained in DMEM with 10% FBS and 100 units/ml penicil-
lin-streptomycin. For transient transfection, cells were
seeded onto 6- or 12-well tissue culture dishes, cultured
overnight, and then transfected using Lipofectamine 2000
(Invitrogen) or SuperFect (Qiagen) according to the man-
ufacturer's instructions. Empty vector was added to adjust
the total amount of DNA to be the same in every transfec-
tion. To establish stable HEK293T cells, the His-CbyWT
expression plasmid was transfected into HEK293T cells
and selected with 500 μg/ml Zeocin (Invitrogen).
Coimmunoprecipitation and Western blotting
HEK293T cell lysates were prepared in lysis buffer con-
taining 20 mM Tris-HCl, pH 8.0, 135 mM NaCl, 1.5 mM
MgCl2, 1 mM EGTA, 1% Triton X-100, 10% glycerol and
complete protease inhibitor cocktail (Roche), and cleared
by centrifugation at 12,000 rpm for 30 min at 4°C. Coim-
munoprecipitation and immunoblotting were performed
as previously described [23,25], except that increasing
concentrations of NaCl and urea were included in wash
buffer for the coimmunoprecipitation experiments shown
in Figure 1D. The primary antibodies used were: mouse
anti-Flag M2 (Sigma); mouse anti-Myc 9E10 (Invitrogen);
rat anti-HA (Roche); rabbit anti-Cby [19]; rabbit anti-β-
catenin (Sigma); rabbit anti-MBP (New England Biolabs);
mouse anti-GST (Novagen).
Synthetic Renilla luciferase (hRluc) protein-fragment-
assisted complementation and TOPFLASH assays
HEK293T cells were seeded onto 12-well plates and trans-
fected with appropriate combinations of plasmids. Luci-
ferase activities were measured using the Dual Luciferase
Reporter Assay System (Promega) and a Berthold lumi-
nometer as previously described [23,25]. An expression
plasmid (10 ng) for Renilla luciferase (pRL-TK) or (5 ng)
of firefly luciferase (pCMV-Luc) was co-transfected to nor-
malize transfection efficiency. For the split hRluc assays
using ViviRen live cell substrate in Figure 1C, cells were
seeded onto 96-well plates and transfected with appropri-BMC Molecular Biology 2009, 10:41 http://www.biomedcentral.com/1471-2199/10/41
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ate combinations of hRluc fusion constructs. The next
day, ViviRen (Promega) was directly added to the tissue
culture media and Renilla luciferase luminescence was
measured according to the manufacturer's instructions.
Cross-linking experiments and gel filtration 
chromatography
His-tagged CbyWT, L77A/L91A and 4A were transiently
expressed in HEK293T cells, and purified using Ni-NTA
His-Bind Resin (Novagen) according to the manufac-
turer's instructions. The purified proteins were dialyzed
against dialysis buffer containing 20 mM Hepes, pH 7.9,
100 mM NaCl, 1 mM EDTA, 0.1% NP-40 and 10% glyc-
erol. An aliquot of the protein samples was incubated in
the absence or presence of freshly prepared glutaralde-
hyde (0.2% final concentration) (Sigma) at 37°C for 5 or
20 min or dimethyl suberimidate (DMS; 2 mg/ml final
concentration) (Sigma) at room temperature for 30 min
in a 40 μl of the dialysis buffer. The glutaraldehyde reac-
tion was stopped by addition of 10 μl of 1 M Tris-HCl, pH
8.0. The samples were then mixed with SDS sample
buffer, boiled and resolved by SDS-PAGE, followed by
immunoblotting with anti-Cby antibody.
For the gel filtration experiment, His-Cby was purified
from ten 15-cm dishes of stable HEK293T cells, and dia-
lyzed against the dialysis buffer as described above for
cross-linking. The protein sample was then loaded onto a
Superdex 75 gel filtration column (Amersham Bio-
sciences), and run via fast protein liquid chromatography
(FPLC) (Amersham Biosciences) with gel filtration buffer
containing 20 mM Tris-HCl, pH 8.0, 0.5 or 1.0 M NaCl, 1
mM EDTA, 2 mM DTT, 2 mM betaine-HCl, 0.02% Triton
X-100 and 5% glycerol at a flow rate of 0.3 ml/min. Frac-
tions of approximately 0.5 ml were collected and analyzed
by Western blotting with anti-Cby antibody. The column
was calibrated using protein standards (Amersham Bio-
sciences): ferritin, 450 kDa; aldolase,158 kDa; bovine
serum albumin, 67 kDa; ovalbumin, 45 kDa; cytochrome
C, 12 kDa.
Protein expression in bacteria and in vitro pull-down 
assays
GST and MBP fusion and His-tagged proteins were
expressed according to the manufacturer's instructions,
and in vitro binding assays were performed essentially as
described previously [19,50].
Immunofluorescence microscopy
Transfected COS7 cells were grown on glass coverslips,
fixed with methanol-acetone (1:1, v/v), permeabilized
with 0.2% Triton X-100 and blocked with 1% BSA in PBS.
Flag-tagged Cby was detected using mouse anti-Flag M2
antibodies (Sigma), followed by TRITC-labelled goat anti-
mouse IgG (Jackson Immunoresearch Laboratories).
Nuclei were counterstained with DAPI (Sigma) and
stained cells were analyzed by a Leica DM5000 fluores-
cent microscope. To quantify subcellular localization,
independent transfections were performed at least three
times, and a minimum of 100 cells were counted for each
transfection.
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